Statistics
Publications
35
Citations
1.4K
H-Index
22
Active since
2013
Liang Lin is an author at Dana-Farber Cancer Institute specializing in multiple myeloma therapy, multiple myeloma, and medicine.
Publications per year
2013–2024
35
35
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 89 citations · Full text
Life Sciences, Immunology, Oncology +14
1–5 of 35